{
  "id": 16620983,
  "title": "STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer",
  "url": "https://urgent.news/2026/10/26/stat-merck-adc-drug-cut-risk-of-death-by-one-third-in-advanced",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-26T15:30:00.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/10/26/merck-kelun-sac-tmt-endometrial-cancer-study-esmo-2026/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "NPR Health",
        "title": "Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer",
        "url": "https://urgent.news/2026/10/26/mercks-melanoma-vaccine-trial-shows-reduced-recurrence-or-death-from",
        "published": "2026-10-26T08:42:43.000Z"
      },
      {
        "outlet": "Seeking Alpha News",
        "title": "Merck's sac-TMT significantly cuts death risk in endometrial cancer",
        "url": "https://urgent.news/2026/10/26/mercks-sac-tmt-significantly-cuts-death-risk-in-endometrial-cancer",
        "published": "2026-10-26T19:53:39.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}